CBYL
Carbylan Therapeutics Inc
Clinical-stage specialty biopharmaceutical company developing proprietary combination therapies
CUSIP: 141384107HealthcareUS1 holder
Total Value
$353.0K
Total Shares
97.6K
Net Share Change
-600
Activity
1 selling
Investor
Value
Shares
Weight
Change
Leon Cooperman
$353.0K97.6K shares
TRIM-600(-0.6%)